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INTRODUCTION
Chronic infection with the carcinogenic liver fluke Opisthor-
chis viverrini results in continuous irritation, chronic inflam-
mation, restlessness tissue damage, and repair of the bile tract, 
including the second order bile ducts [1]. Consequently, infec-
tion with O. viverrini is strongly associated with chronic hepa-
tobiliary disease, including cholangitis, cholecystitis, obstruc-
tive jaundice, advanced periductal fibrosis, and cholangiocarci-
noma (CCA) [1,2]. Ultrasonographic assessment of hepatobil-
iary abnormalities of otherwise asymptomatic persons stool 
positive for infection with O. viverrini revealed that about 25% 
of these cases developed advanced periductal fibrosis, and 
CCA was suspected in up to 0.5% of them based on abdomi-
nal ultrasound examinations [3,4]. The mechanism underly-
ing the different outcomes of O. viverrini infection is unknown. 
Our extensive research experience with opisthorchiasis led us 
the suspect that host inflammatory responses to the liver fluke 
might play pivotal roles in the outcome [1,2]. Inflammation 
mediated by cytokines has been described in infectious diseas-
es and malignancies [5,6]. Specifically, the liver fluke infection 
induces marked inflammation characterized by infiltration by 
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Abstract: Opisthorchis viverrini infection induces chronic inflammation, and a minor proportion of infected individuals de-
velop advanced periductal fibrosis (APF) and cholangiocarcinoma (CCA). Inflammatory cytokines and/or their gene poly-
morphisms may link to these biliary pathologies. We therefore investigated associations among cytokine gene polymor-
phisms and cytokine production in 510 Thai cases infected with O. viverrini who presented with APF+ or APF-, as estab-
lished by abdominal ultrasonography as well as in patients diagnosed with CCA. Levels of pro-inflammatory and anti-in-
flammatory cytokines were determined in culture supernatants after stimulation of peripheral blood mononuclear cells 
(PBMCs) with O. viverrini excretory-secretory (ES) products. Pro-inflammatory cytokines, IL-1β, IL-6, IFN-γ, LT-α, and 
TNF-α were significantly increased in CCA patients compared with non-CCA (APF- and APF+) cases. Polymorphisms in 
genes encoding IL-1β -511C/T, IL-6 -174G/C, IFN-γ +874T/A, LT-α +252A/G, and TNF-α -308G/A were then investigated 
by using PCR-RFLP or allele specific-PCR (AS-PCR) analyses. In the CCA cases, LT-α +252A/G and TNF-α -308G/A het-
erozygous and homozygous variants showed significantly higher levels of these cytokines than the wild type. By contrast, 
levels of cytokines in wild type of IFN-γ +874T/A were significantly higher than the variants in CCA cases. IFN-γ +874T/A 
polymorphisms were associated with advanced periductal fibrosis, whereas IL-6 -174G/C polymorphisms were associat-
ed with CCA. To our knowledge, these findings provide the first demonstration that O. viverrini infected individuals carry-
ing several specific cytokine gene polymorphisms are susceptible to develop fibrosis and CCA. 
Key words: Opisthorchis viverrini, hepatobiliary disease, advanced periductal fibrosis, cholangiocarcinoma, cytokine gene polymorphisms
296  Korean J Parasitol Vol. 55, No. 3: 295-304, June 2017
neutrophils and mononuclear cells into the vicinity of the in-
fected bile ducts. Proteins and other metabolites released by 
the O. viverrini worms activate Toll-like receptor 4 and induce 
expression of the potent chemo-attractant IL-8 and pro-in-
flammatory IL-6 cytokines [7]. 
Gene polymorphisms affect the cytokine expression and in-
fluence inflammatory processes in response to infectious dis-
eases and cancer [8]. In the context of liver fluke infection, 
hepatobiliary disease and associated bile duct cancer, we have 
reported marked elevation in expression of IL-6 in response to 
O. viverrini excretory-secretory (ES) antigens during chronic 
opisthorchiasis, particularly where biliary periductal fibrosis is 
marked [9]. In addition, we observed significant increases in 
both pro-inflammatory and anti-inflammatory cytokines dur-
ing cholangiocarcinoma associated with chronic liver fluke in-
fection [10]. We now hypothesize that cytokine gene polymor-
phisms influence cytokine expression profiles, which in turn 
may result in diverse pathogenic sequelae during infection 
with O. viverrini. This study described below investigated asso-
ciations among cytokine gene polymorphisms and cytokine 
production during chronic opisthorchiasis and associated bili-
ary tract diseases, including CCA.
MATERIALS AND METHODS
Study participants
This study was approved by the Khon Kaen University Hu-
man Ethics Committee, reference nos. HE480528 and HE 
581272. Written informed consents were obtained from all 
participants or patients. Four hundred participants positive for 
infection with O. viverrini, including 200 without APF- and 
200 with APF+, were recruited from sites endemic for O. viver-
rini infection in Khon Kaen or neighboring provinces in north-
eastern Thailand, as described [9]. This study also included 110 
histologically proven cases of cholangiocarcinoma (CCA); 
these latter participants had undergone hepatectomy at Sri-
nagarind Hospital, Faculty of Medicine, Khon Kaen University, 
Khon Kaen, Thailand. 
Opisthorchis viverrini-ES product preparation
ES products of O. viverrini (Ov-ES) were prepared as de-
scribed [11,12]. Briefly, viable liver flukes recovered at necropsy 
from experimentally infected hamsters were cultured in RPMI-
1640 containing antibiotics and the protease inhibitors (0.1 
mM phenylmethanesulfonyl fluoride (PMSF), 1 mM leu-
peptin and 0.1 mM N-[N-(L-3-trans-carboxyoxiran-2-carbon-
yl)- L-leucine]-agmatine, E-64). The cultures were maintained 
in vitro at 37˚C and supernatants containing the Ov-ES were 
collected twice daily for 7 days. The culture supernatants were 
subjected to centrifugation at 3,000 g for 10 min to pellet the 
eggs. Clarified supernatants were pooled, dialyzed against PBS, 
and concentrated by membrane ultrafiltration (PM 10, Ami-
con, Danvers, Masssacusetts, USA). Lipopolysaccharide (LPS) 
was removed using Triton-X114 extraction [13], followed by 
passage through Bio-Beads SM2 (Bio-Rad, Hercules, CA, USA) 
to remove Triton-X114. Finally, OvES was filtered through a 0.2 
μm membrane and then aliquoted and stored at -80˚C. The 
LPS concentration was determined using the Limulus amebo-
cyte assay (less than 100 ng/ml failed to affect cell proliferation 
or cytokine production, unpublished) [14]. 
Peripheral blood mononuclear cells (PBMCs) culture
PBMC were isolated from heparinized blood by density gra-
dient centrifugation using Ficoll-Paque (Sigma Diagnostic, St. 
Louis, Missouri, USA), counted on a hematocytometer and vi-
ability assessed using 0.5% Trypan blue dye. PBMC were cul-
tured at 2×104 cells/ml in RPMI-1640 supplemented with an-
tibiotics and 5% fetal bovine serum with or without Ov-ES, 20 
µg/ml. Phytohemaglutinin (PHA)-L (Difco Laboratories, De-
troit, Michigan, USA) at 10 μg/ml was used as positive control 
of cytokine stimulation. The cells were cultured at 37˚C in a 
humidified 5% CO2 incubator for 48 hr. Supernatants were 
harvested and stored at -80˚C for cytokine level determination. 
Cytokine detection
A 25-50 µl of supernatant was used for cytokine assays. The 
secreted cytokines were quantified using the FlowCytomix 
bead-based multiplexing assays kit, human Th1/Th2 (IFN-γ, 
IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, TNF-α, and 
LT-α) 11-plex kit (BMS810FF, BenderMedSystems, Vienna, Aus-
tria) and quantified using flow cytometry (FC500, Beckman-
Coulter, Brea, California, USA). Cytokine levels were estab-
lished by interpolation from standard curves established using 
human recombinant cytokines (BMS8400FF, BenderMedSys-
tems), after which the findings were expressed as pg/ml.
DNA extraction and genotyping
Genomic DNA was extracted from PBMC from each partici-
pant using the Puregene DNA Isolation Kit (Gentra systems, 
Minneapolis, Minnesota, USA), quantified using the Nano-
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Drop ND-1000 and stored at −20°C. Single nucleotide poly-
morphisms (SNPs) for IL-1β -511C/T, IL-6 -174G/C, LT-α 
+252A/G, and TNF-α -308G/A polymorphisms were analyzed 
by restriction fragment length polymorphism (RFLP), as de-
Table 1. Primer sequences, restriction enzymes, and size of digestion products in the PCR-RFLP and AS-PCR analyses  
Gene/SNP rsn wt/var Region Oligonucleotide primers RE Digestion products (bp)
IL-1β/-511 rs16944 C/T Promoter F (5'- TGG CAT TGA TCT GGT TCA TC-3') Ava I wt: 190, 114
R (5'-GTT TAG GAA TCT TCC CAC TT-3') var: 304
IL-6/-174 rs1800795 G/C Promoter F (5'-GGG CTG CGA TGG AGT CGA AG-3') Nla III wt: 233, 54
R (5'-TCC CTC ACA CAG GGC TCG-3') var: 122. 111, 54
IFN-γ/+874 rs2430561 T/A Intron 1 Common primer: 5'TCAACAAAGCTGATACTCCA-3',    
T allele primer: 5'TTCTTACAACACAAAATCAAATCT-3',
A allele primer: 5'TCTTACAACACAAAATCAAATCA-3'
LT-α/+252 rs909253 A/G intron F (5'-CCG TGC TTC GTG CTT TGG ACT A-3') Nco I wt: 427
R (5'-AGA CGT TCA GGT GGT GTA AT-3') var: 231, 196
TNF-α/-308 rs1800629 G/A promoter F (5'-TCC TCC CTG CTC CGA TTA CG-3') Nco I wt: 87
R (5'-AGG CAA TAG GTT TTG AGG GCC-3') var: 107
SNP, Single nucleotide polymorphism; rsn, reference SNP number; wt, wild type; var, variant; RE, restriction enzyme; bp, base pair  
Fig. 1. Representative amplicons and digestion fragments corresponding to gene polymorphisms. (A) 190 and 114 bp fragments specific for 
C allele, 304 bp fragment specific for T allele of IL-1b-511C/T polymorphism. (B) 233 bp and 54 bp bands specific for G allele, 122 bp, 111 
bp, and 54 bp bands specific for C allele of IL-6-174G/C polymorphism. C) 262 bp fragment specific for T and A alleles of IFN-γ +874T/A 
polymorphism. (D) 427 bp fragment specific for A allele, 231 and 196 bp fragments specific for G allele of LT-α +252A/G polymorphism. (E) 
107 bp fragment specific for A allele, 87 bp fragments specific for G allele of TNF-α -308G/A polymorphism. M, 50 bp DNA marker. 
304 bp
233 bp
320 bp
190 bp
122 bp
262 bp
114 bp
111 bp
54 bp
A B 
C D E
IL-1β-511 C/T
IFN-γ+874T/A
IL-6-174 G/C
LT-α+252A/G TNF-α-308G/A
M M1 12 23 34 45 5 6
M 1 2 3 4 5 6 M 1 2 3 M 1 2 3 4 5 6
427 bp
231 bp
107 bp
196 bp
87 bp
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scribed [15-18]. Allele specific-PCR (AS-PCR) was used to ana-
lyze for IFN-γ +874T/A polymorphism [19]. Table 1 lists the 
PCR thermal cycling conditions and oligonucleotide primers 
specific for 5 cytokine gene polymorphisms, IL-1β -511C/T, 
IL-6 -174G/C, IFN-γ +874T/A, LT-α +252A/G, and TNF-α 
-308G/A. Amplified products were evaluated by 1.5% (IFN-γ), 
3.0% (IL-6, LT-α and TNF-α), and 8.0% (IL-1β) agarose gel 
electrophoresis containing ethidium bromide (0.5 μg/ml). Af-
ter electrophoresis, the ethidium-stained fragments were visu-
alized and documented (Multi Doc-ItTM Digital Imaging Sys-
tem, UVP, Upland, California, USA) (Fig. 1). 
Statistical analysis
The Kolmogorov-Smirnov test was used to test whether the 
data were distributed normally. Statistical analysis was per-
formed with non-parametric tests (Kruskal-Wallis and Mann-
Whitney), with assistance of the IBM SPSS Statistics for Win-
dows package, version 19 (SPSS, Chicago, Illinois, USA). Har-
dy-Weinberg equilibrium (HWE) analyses (chi-square tests, 
χ2) were used to compare the expected and observed genotype 
frequencies in the non-CCA groups of study participants. Al-
lele frequency differences between cases (CCA) and controls 
(non-CCA) were analyzed, and the odd ratios (OR) and 95% 
confidence intervals (95% CI) were calculated. 
RESULTS
Demographic and clinicopathological characteristics
Table 2 summarizes the clinicopathological characteristics 
of participants in this study who had been diagnosed with 
CCA as well as the liver fluke infected cases without CCA. The 
APF- group included 109 females and 91 males, mean age of 
46.8 years (range, 20-60 years) and the APF+ group included 
108 females and 92 males, mean age of 47.4 years (range, 25-
60 years). The CCA group was composed of 72 men and 38 
women, and the mean age was 55.9 years (range, 40-76 years). 
Cytokine production in Ov-ES stimulated PBMCs 
Fig. 2 summarizes the net production of all cytokines quan-
tified following Ov-ES stimulation of PBMC from the APF-, 
APF+, and CCA cases. Levels of IL-1β, IFN-γ, and LT-α were 
significantly higher in CCA patients compared with the APF- 
and APF+ groups. TNF-α production was significantly higher 
in CCA and APF+ groups compared with APF-. Notably, IL-6 
was significantly higher in APF+ cases compared with the CCA 
and APF- groups. Differences were not apparent among the 
groups for 6 other cytokines, IL-2, IL-4, IL-5, IL-8, IL-10, and 
IL-12p70. 
Gene polymorphism and cytokine production
Overall comparison regardless of CCA or non-CCA groups 
did not reveal significant differences in levels of cytokines 
among gene polymorphisms except for LT-α, where net cyto-
kine production in LT-α +252A/G heterozygous (AG) and ho-
mozygous (GG) variants were significantly elevated compared 
to the wild type (Fig. 3). However, when subdividing into CCA 
and non-CCA groups (APF- and APF+), LT-α +254A/G hetero-
zygous (AG), and homozygous (GG) variants showed signifi-
cantly higher levels of cytokines than the wild type in CCA 
group; 2.35-fold and 2.24-fold, respectively. Similarly, TNF-α-
308G/A heterozygous (GA) and homozygous (AA) variants 
showed significantly higher levels of cytokines than the wild 
type in CCA group with fold changes of 12.49 and 4.76, re-
spectively. Interestingly, IFN-γ+874T>A heterozygous (TA) 
and homozygous (AA) was significantly lower (0.56- and 0.2-
fold, respectively) than the wild type in the CCA group. 
Distribution of cytokine gene polymorphisms among 
patient groups
Table 4 presents the genotypes and allele distribution of IL-
1β -511C/T, IL-6 -174G/C, IFN-γ+874T/A, LT-α +254A/G, and 
TNF-α-308G/A polymorphisms in the participants, those with 
APF-, APF+, and CCA. Comparison among groups did not re-
veal significant differences in the genotype or allele frequen-
cies for IL-1β -511C/T, LT-α +252A/G, and TNF-α-308G/A. 
However, comparing the IL6 -174G/C genotypes between the 
CCA and non-CCA (APF- or APF+) groups revealed that the 
presence of heterozygous (GC) genotype associated with CCA 
Table 2. Clinicopathological characteristics of cholangiocarcino-
ma (CCA) patients and non-CCA controls   
Demographics APF- (n=200) APF+ (n=200) CCA (n=110)
Sex
   Male (%)
   Female (%)
 
91 (45.5)
109 (54.5)
 
92 (46.0)
108 (54.0)
 
72 (65.5)
38 (34.5)
Age (years)
   Mean±SD
   Range
 
46.8 ±7.7
20-60
 
47.4±7.5
22-60
 
55.9±10.3
40-76
Age (in year; %)
   ≤  30
   31-40
   41-50
   ≥  51
 
6 (3.0)
34 (17.0)
86 (43.0)
74 (37.0)
 
5 (2.5)
33 (16.5)
83 (41.5)
79 (39.5)
 
1 (0.9)
5 (4.6)
20 (18.2)
84 (46.4)
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(OR=2.35 and 2.95 for APF- vs CCA and APF+ vs CCA, re-
spectively). Moreover, a stronger association with CCA was 
found with the homozygous variant (CC) (OR=5.50 and 7.52 
for APF- vs CCA and APF+ vs CCA, respectively). In addition, 
C alleles at this locus also associated with CCA (OR=3.36) 
when the CCA and APF+ groups were compared. Comparing 
between APF+ and APF- groups, IFN-γ+874T>A heterozygous 
(TA) and homozygous (AA) variants associated with biliary 
periductal fibrosis (OR=3.10 and 2.74, respectively). The IFN-
γ+874T>A homozygous variant (AA) genotype was also asso-
ciated with CCA (OR=2.20) as compared between APF- and 
CCA groups, whereas the A allele associated with both fibrosis 
(OR=1.60, APF- vs APF+) and CCA (OR=1.71, APF- vs CCA). 
In the case of TNF-α -308G/A polymorphism, only the TNF-α 
-308 A allele appeared to be associated with CCA (OR=1.61 
and OR=1.5 in APF- vs CCA and in APF+ vs CCA, respectively). 
DISCUSSION
Infection with the liver fluke O. viverrini frequently leads to 
chronic inflammation of the bile ducts and results in unremit-
ting tissue damage that, in turn, can cause hepatobiliary dis-
Table 3. Cytokine levels as established in PBMCs pulsed with 
excretory secretory profcuts of the liver fluke Opisthorchis viverrini 
and the net cytokine production and genotype polymorphisms 
 
Cytokine levels, pg/ml
Wild type Heterozygous Variant
IL-1β 268.4±47.7 315.4±35.9 303.1±41.1
IL-6 3,973.1±763.2 4,221.6±434.8 4,323.7±440.5
IFN-γ 514.9±140.3 397.5±117.4 239.9±65.2
LT-α 67.3±17.9 187.4±36.0* 153.7±36.7*
TNF-α 362.6±68.8 498.8±127.1 466.7±67.9
Cytokine levels presented as mean±SD; * P<0.05; n=510. 
Fig. 2. Net cytokine profile of OvES stimulated PBMCs in APF-, APF+, and CCA patients. The Wilcoxon Matched-paired Signed rank 
test was used to assess the statistical significance; *P<0.05.
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Fig. 3. The net production of IL-1β, IL-6, IFN-γ, LT-α, and TNF-α, and their genotype polymorphisms in APF- (n=200), APF+ (n=200), 
and CCA patients (n=110). wt, wild type; hetero, heterozygous; var, variant. 
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eases including CCA. A subset of people with opisthorchiasis 
develop overt hepatobiliary disease, with about 25% of them 
displaying marked biliary tract fibrosis and as many as 0.5% 
of infected cases exhibiting incipient bile duct cancer upon ul-
trasound examination [4,20,21]. Why infection leads to differ-
ent disease outcomes among the population in high liver fluke 
infection endemic sites remains to be established. Divergent 
immunological responses among infected persons may con-
tribute to the outcome, in addition to other co-factors [22]. 
The pro-inflammatory cytokine IL-6 is significantly elevated in 
infected individuals with marked and chronic hepatobiliary fi-
brosis [9,23] and cholangiocytes upregulate expression of IL- 6 
and IL-8 in response to the Ov-ES components [24,25]. More-
over, the recent study revealed both pro-inflammatory and an-
ti-inflammatory cytokines were increased in the O. viverrini-as-
sociated CCA compared to uninfected normal controls [10]. 
Here, we investigated pro-inflammatory and anti-inflamma-
tory cytokine profiles among different groups of patients in-
fected with O. viverrini: liver fluke infected individuals exhibit-
ing biliary tract disease (advanced periductal fibrosis, APF+) or 
without overt biliary periductal fibrosis (APF-), and liver fluke 
infection-associated CCA cases. We observed that pro-inflam-
matory cytokines, IL-1β, IL-6, IFN-γ, LT-α, and TNF-α, though 
no other cytokines were increased significantly during CCA in 
comparison with participants infected with O. viverrini but 
without CCA, i.e., the APF- and APF+ groups. These findings 
indicated that marked inflammatory responses during opis-
thorchiasis increased the risk for cholangiocarcinogenesis. 
Gene polymorphisms are known to affect cytokine levels 
[8,26,27].  Single nucleotide polymorphism (SNP) can affect 
gene function in many ways [28]. If it occurs at the non-coding 
region, it can affect the binding of transcriptional factors, inter-
fere RNA splicing, and increase or decrease messenger RNA 
degradation. SNP in coding region can result in 2 consequenc-
Table 4. Comparison of genotypes and allele frequencies for IL-1β, IL-6, IFN-γ, LT-α, and TNF-α in CCA cases and the participants in 
the APF+ and the APF- groups      
Cytokine/ 
 Genotype/Allele
APF-N(%) APF+N(%) CCA N(%)
APF- vs. APF+ APF- vs. CCA APF+ vs. CCA
OR (95% CI) OR (95% CI) OR (95% CI)
IL-1β (-511C/T)
   CC
   CT
   TT
   C
   T
 
38 (19.0)
100 (50.0)
62 (31.0)
176 (44.0)
244 (56.0)
 
36 (18.0)
93 (46.5)
71 (35.5)
165 (41.2)
235 (58.8)
 
18 (16.1)
48 (43.6)
44 (40.0)
84 (38.2)
136 (61.8)
 
1
0.98 (0.50- 1.74)
1.20 (0.65-2.22)
1
1.02 (0.77-1.36)
 
1
1.01 (0.50-2.09)
1.49 (0.72-3.16)
1
1.16 (0.82-1.65)
 
1
1.03 (0.50-2.14)
1.23 (0.59-2.61)
1
1.13 (0.80-1.61)
IL-6 (-174G/C)
   GG
   GC
   CC
   G
   C
 
112 (56.0)
67 (33.5)
21 (10.5)
291 (72.7)
109 (27.3)
 
124 (62.0)
59 (29.5)
17 (8.5)
307 (76.7)
93 (23.3)
 
32 (29.1)
45 (40.9)
33 (30.0)
109 (49.5)
111 (50.5)
 
1
0.79 (0.50-1.25)
0.73 (0.34-1.53)
1
0.81(0.58-1.13)
 
1
2.35 (1.31-4.21)*
5.50 (2.65-11.41)*
1
0.26 (0.12-0.52)
 
1
2.95 (1.64-5.31)*
7.52 (3.52-16.19)*
1
3.36 (2.32-4.85)*
IFN-γ (+874T/A)
   TT
   TA
   AA
   T
   A
 
61 (30.5)
74 (37.0)
65 (32.5)
196 (49.0)
204 (51.0)
 
26 (13.0)
98 (49.0)
76 (38.0)
150 (37.5)
250 (62.5)
 
23 (20.9)
33 (30.0)
54 (49.1)
79 (35.9)
141 (64.1)
 
1
3.10 (1.73-5.61)*
2.74 (1.50-5.04)*
1
1.60 (1.19-2.14)*
 
1
1.18 (0.60-2.34)
2.20 (1.13-4.20)*
1
1.71 (1.20-2.44)*
 
1
0.38 (0.18-0.80)
0.80 (0.39-1.64)
1
1.07 (0.75-1.5)
LT-α (+252A/G)
   AA
   AG
   GG
   A
   G
 
60 (30.0)
74 (37.0)
66 (33.0)
194 (48.5)
206 (51.5)
 
47 (23.5)
93 (46.5)
60 (30.0)
187 (46.8)
213 (53.2)
 
24 (21.8)
54 (49.1)
32 (29.1)
102 (46.4)
118 (53.6)
 
1
1.60 (0.95-2.65)
1.16 (0.66-2.01)
1
1.07 (0.80-1.43)
 
1
1.84 (0.97-3.45)
1.21 (0.61-2.40)
1
1.08 (0.77-1.53)
 
1
1.17 (0.60-2.16)
1.04 (0.51-2.11)
1
1.01 (0.72-1.43)
TNF-α (-308G/A)
   GG
   GA
   AA
   G
   A
 
34 (17.0)
54 (27.0)
112 (56.0)
122 (30.5)
278 (69.5)
 
35 (17.5)
46 (23.0)
119 (59.5)
116 (29.0)
284 (71.0)
 
17 (15.5)
13 (11.8)
80 (72.7)
47 (21.4)
173 (78.6)
 
1
0.82 (0.42-1.60)
1.03 (0.58-1.83)
1
1.07 (0.78-1.47)
 
1
0.48 (0.18-1.20)
1.42 (0.71-2.92)
1
1.61 (1.08-2.43)*
 
1
0.58 (0.22-1.47)
1.38 (0.69-2.82)
1
1.50 (1.00-2.26)*
*Significant at P-value<0.05.      
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es; synonymous and nonsynonymous SNPs. Synonymous 
SNPs do not affect the protein sequence, but can still affect the 
protein conformation such as the silent polymorphism in the 
MDR1 gene changes substrate specificity [29]. Nonsynony-
mous SNPs change the amino acid sequence of protein and 
subsequent protein function as shown in cystic fibrosis pa-
tients [30]. For SNPs in our liver fluke associated CCA, we re-
port here that certain cytokine gene polymorphisms affect 
proinflammatory cytokine production. However, detail molec-
ular mechanisms need to be further investigated.
Accordingly, we hypothesized that cytokine gene polymor-
phisms may underline variations in inflammatory cytokine re-
sponse in response to liver fluke infection and downstream 
biliary tract inflammation and cholangiocarcinogenesis. The 
gene polymorphisms IL-1β -511C/T, IL6 -174G/C, LT-α +252A/
G, and TNF-α-308G/A generated the high-producer pheno-
types, whereas IFN-γ+874T/A exhibited a low-production phe-
notype. In agreement with these reports, both LT-α +252A/G 
and TNF-α-308G/A heterozygous and homozygous variants 
showed significant higher levels of cytokine than the wild type. 
Similarly, both IL-1β -511C/T and IL-6 -174G/C variants pro-
duced more cytokines than the wild type, even though the dif-
ference was not statistically significant. By contrast, the variants 
of IFN-γ+874T/A produced less cytokines than the wild type. 
We note, however, that these cytokine production profiles were 
observed only in the CCA cases, and not among the non-CCA 
groups. The difference of cytokine production from the same 
gene polymorphism between non-CCA and CCA patients 
might indicate divergence in cytokine regulation/networking 
among the groups in this study. 
Subsequently we investigated whether gene polymorphisms 
of these pro-inflammatory cytokine were related to the devel-
opment of fibrosis or CCA. An IL-6 -174G>C polymorphism 
represents a potential modulator of risk for malignancy with 
ethnicity and tumor site dependent trends [31]. The present 
findings revealed that both heterozygous (GC) and homozy-
gous (CC) variant of IL6 -174G>C polymorphisms were asso-
ciated with cholangiocarcinogenesis in this Thai population. 
Given that the heterozygous (GC) and homozygous (CC) 
variants of IL6 -174G>C are high producer phenotypes, these 
gene polymorphisms might explain elevated levels of IL-6 dur-
ing in CCA, as reported earlier. The A allele of the TNF-α 
-308G/A polymorphism appears to associate with the disease 
progression of hepatitis B viral infection and hepatocellular 
carcinoma [32]. In likely fashion, the present findings revealed 
that the A allele of TNF-α-308G/A polymorphism associated 
with CCA.
Interferon gamma plays key roles in the immune responses 
and in antitumor mechanisms [33,34]. IFN-γ+874T>A poly-
morphisms are associated with viral and bacterial infections, 
which result in chronic inflammation and carcinogenic [35-
37]. Here, IFN-γ+874T>A heterozygous (TA) and homozy-
gous (AA) variants associated with fibrosis, and the IFN-
γ+874T>A homozygous (AA) variant was also associated with 
CCA. As noted, these variants produce less IFN-γ than the TT 
(wild type) genotype. Together these findings indicate that in a 
subset of liver fluke infected individuals carrying these alleles, 
the phenotype of which is reduced levels of IFN-γ, are at ele-
vated risk for biliary periductal fibrosis and CCA.  Mechanisms 
underlying the association are not known. However, for anti-
tumor activity, IFN-γ plays a central role in the recognition and 
elimination of transformed cells through its cytostatic, pro-
apoptotic, and immune-provoking effects [33]. 
To summarize, cytokine and gene polymorphism profiles of 
Thais infected with the liver fluke O. viverrini were character-
ized. To our knowledge, this is the first demonstration that 
persons infected with O. viverrini inherited with certain gene 
polymorphisms that result in aberrant cytokine production 
are susceptible to develop fibrosis and CCA. Pro-inflammatory 
cytokines were increased in persons with cholangiocarcinoma 
(CCA). Different cytokine gene polymorphisms were found 
among patients with or without fibrosis and CCA. Interesting-
ly, a subset of patients with the IL6 -174G>C polymorphisms, 
the IFN-γ+874T>A heterozygous (TA) and homozygous (AA) 
variants, and the A allele of TNF-α -308G/A associated with 
CCA. Further studies on these gene polymorphisms and in re-
lation to other cytokines are warranted since they may identify 
genotypes and phenotypes predictive of risk for CCA. 
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